Global Compounding Pharmacies Market: Analysis By Product Type (Oral, Topical, Ophthalmic, Injectables, Others), By Therapeutic Area, End User (Adult, Pediatric, Geriatric, Veterinary), By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) - By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, Others), By Region (North America, Europe, APAC, ROW), By Country (US, Canada, UK, Germany, China, Japan, India, Brazil, Mexico)

Global Compounding Pharmacies Market: Analysis By Product Type (Oral, Topical, Ophthalmic, Injectables, Others), By Therapeutic Area, End User (Adult, Pediatric, Geriatric, Veterinary), By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) - By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, Others), By Region (North America, Europe, APAC, ROW), By Country (US, Canada, UK, Germany, China, Japan, India, Brazil, Mexico)

Jul 2019 Azoth Analytics Pharmaceutical260 Pages Price :
$ 2400

A comprehensive research report created through extensive primary research (inputs from industry experts, companies and stakeholders) and secondary research, the report aims to present the analysis of Global Compounding Pharmacies Market. The report has further analysed the Compounding Pharmacies Market by By Product Type (Oral, Topical, Ophthalmic, Injectables and Others), By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology and Others) and By End User (Adult, Pediatric, Geriatric and Veterinary). The Global Compounding Pharmacies Market has been analysed By Region (North America, Europe, Asia Pacific, ROW) and By Country (United States, Canada, United Kingdom, Germany, China, Japan, India, Brazil and Mexico) for the historical period of 2014-2018 and the forecast period of 2019-2024.

Valued at approximately USD 9689.56 million in the year 2018, the global compounding pharmacies market is being influenced by several key factors such as rising share of elderly individuals, increase in per capita expenditure on healthcare as well as the rising trend of adopting personalized medicines. Furthermore, increasing population growth rate with a significant share of people suffering from a slew of diseases such as cancers, cardiovascular disorders, hormonal imbalances, etc., have been propelling the demand for customized pharmaceutical products that can be most effective to their individual health conditions. Furthermore, the “one-size-fits-all” characteristic of majority of mass produced drugs means that several patients’ requirements are not met. In such circumstances, the patients often rely on the services provided by the compounding pharmacies. Above and beyond, patients utilizing personalized compounded medications often experience fewer side effects than those treated with generic medications. Within the different therapeutic areas of compounded pharmaceutical products, hormone replacement therapy and pain management remained the chief money-spinning segments. On the basis of end user, the global compounding pharmacies market is dominated by adults encompassing the age group of 19 to 64 years. 

The report titled has covered and analysed the potential of global compounding pharmacies market and provides statistics and information on market size, shares, market attractiveness and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation.

Scope of the Report

Global Compounding Pharmacies Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • Global Market – Sizing, Growth, Forecast
  • Analysis by Product Type – Oral, Topical, Ophthalmic, Injectables, Others 
  • Analysis by Therapeutic Area - Hormone Replacement, Pain Management, Dermatology, Others
  • Analysis by End User - Adult, Pediatric, Geriatric, Veterinary
  • Market Attractiveness of Compounding Pharmacies Market By Product, Therapeutic Area, By End-User

Regional Compounding Pharmacies Market– North America, Europe, Asia Pacific, ROW (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • Regional Market – Sizing, Growth, Forecast
  • Analysis by Product Type – Oral, Topical, Ophthalmic, Injectables, Others 
  • Analysis by Therapeutic Area - Hormone Replacement, Pain Management, Dermatology, Others
  • Analysis by End User - Adult, Pediatric, Geriatric, Veterinary
  • Regional Market Attractiveness of Compounding Pharmacies Market By Country

Country Analysis – United States, Canada, United Kingdom, Germany, India China, Japan, Brazil, Mexico (Actual Period: 2014-2018, Forecast Period: 2019-2024)
Compounding Pharmacies Market – Sizing, Growth, Forecast

Other Report Highlights:

  • Market Dynamics – Drivers and Restraints
  • Market Trends
  • Competitive Landscape, Company Share Analysis, Merger and Acquisitions of Key Industry Players
  • SWOT Analysis
  • Porter Five Force Analysis
  • Policy and Regulatory Landscape

Company Analysis – Fagron, PharMEDium, Dougherty’s Pharmacy, ITC Compounding Pharmacy, Fresenius Kabi, Clinigen Group, Absolute Pharmacy, McGuff Compounding Pharmacy Services, Inc., and Harrow Health, Inc.

Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.  

Table of Content

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Compounding Pharmacies Market Outlook

5. Global Compounding Pharmacies Market: Growth and Forecast
5.1 By Value (2014-2018)
5.2 By Value (2019-2024)

6. Global Compounding Pharmacies Market: Segment Analysis
6.1 Global Compounding Pharmacies Market, By Product Type:
6.1.1 Global Compounding Pharmacies Market Size, By Product Type, By Value - 2018 (In %)
6.1.2 Global Compounding Pharmacies Market Size, By Product Type, By Value - 2024 (In %)
6.1.3 Global Compounding Pharmacies Market, By Oral Preparations, By Value (2014-2018)
6.1.4 Global Compounding Pharmacies Market, By Oral Preparations, By Value (2019-2024)
6.1.5 Global Compounding Pharmacies Market, By Topical Preparations, By Value (2014-2018)
6.1.6 Global Compounding Pharmacies Market, By Topical Preparations, By Value (2019-2024)
6.1.7 Global Compounding Pharmacies Market, By Ophthalmic Preparations, By Value (2014-2018)
6.1.8 Global Compounding Pharmacies Market, By Ophthalmic Preparations, By Value (2019-2024)
6.1.9 Global Compounding Pharmacies Market, By Injectable Preparations, By Value (2014-2018)
6.1.10 Global Compounding Pharmacies Market, By Injectable Preparations, By Value (2019-2024)
6.1.11 Global Compounding Pharmacies Market, By Other Preparations, By Value (2014-2018)
6.1.12 Global Compounding Pharmacies Market, By Other Preparations, By Value (2019-2024)
6.1.13 Market Opportunity of Global Compounding Pharmacies Market - By Product Type
6.2 Global Compounding Pharmacies Market: Analysis By Therapeutic Area
6.2.1 Global Compounding Pharmacies Market Size, By Therapeutic Area, By Value - 2018 (In %)
6.2.2 Global Compounding Pharmacies Market Size, By Therapeutic Area, By Value - 2024 (In %)
6.2.3 Global Compounding Pharmacies Market, By Hormone Replacement Application, By Value (2014-2018)
6.2.4 Global Compounding Pharmacies Market, By Hormone Replacement Application, By Value (2019-2024)
6.2.5 Global Compounding Pharmacies Market, By Pain Management Application, By Value (2014-2018)
6.2.6 Global Compounding Pharmacies Market, By Pain Management Application, By Value (2019-2024)
6.2.7 Global Compounding Pharmacies Market, By Dermatology Application, By Value (2014-2018)
6.2.8 Global Compounding Pharmacies Market, By Dermatology Application, By Value (2019-2024)
6.2.9 Global Compounding Pharmacies Market, By Other Therapeutic Areas, By Value (2014-2018)
6.2.10 Global Compounding Pharmacies Market, By Other Therapeutic Areas, By Value (2019-2024)
6.2.10 Market Opportunity of Global Compounding Pharmacies Market - By Therapeutic Area
6.3 Global Compounding Pharmacies Market: Analysis By End User
6.3.1 Global Compounding Pharmacies Market Size, By End User, By Value - 2018 (In %)
6.3.2 Global Compounding Pharmacies Market Size, By End User, By Value - 2024 (In %)
6.3.3 Global Compounding Pharmacies Market, By Adult End User, By Value (2014-2018)
6.3.4 Global Compounding Pharmacies Market, By Adult End User, By Value (2019-2024)
6.3.5 Global Compounding Pharmacies Market, By Pediatric End User, By Value (2014-2018)
6.3.6 Global Compounding Pharmacies Market, By Pediatric End User, By Value (2019-2024)
6.3.7 Global Compounding Pharmacies Market, By Geriatric End User, By Value (2014-2018)
6.3.8 Global Compounding Pharmacies Market, By Geriatric End User, By Value (2019-2024)
6.3.9 Global Compounding Pharmacies Market, By Veterinary End User, By Value (2014-2018)
6.3.10 Global Compounding Pharmacies Market, By Veterinary End User, By Value (2019-2024)
6.3.11 Market Opportunity of Global Compounding Pharmacies Market - By End User

7. Global Compounding Pharmacies Market: Regional Analysis
7.1 Global Compounding Pharmacies Market Size, By Region: Breakdown (%)
7.1.1 Global Compounding Pharmacies Market Size, By Region, 2018 (%)
7.1.2 Global Compounding Pharmacies Market Size, By Region, 2024F (%)
7.2 North America Compounding Pharmacies Market: Growth and Forecast
7.2.1 By Value (2014-2018)
7.2.2 By Value (2019-2024)
7.2.3 North America Compounding Pharmacies Market- Company Share Analysis
7.2.4 By Product Type, By Value (2014-2018)
7.2.5 By Product Type, By Value (2019-2024)
7.2.6 By Therapeutic Area, By Value (2014-2018)
7.2.7 By Therapeutic Area, By Value (2019-2024)
7.2.8 By End User, By Value (2014-2018)
7.2.9 By End User, By Value (2019-2024)
7.3 North America Compounding Pharmacies Market: Country Analysis (U.S, Canada)
7.3.1 Market Attractiveness Chart of North America Compounding Pharmacies Market – By Country, By Value
7.3.2 North America Compounding Pharmacies Market Size, By Country, 2018 (%)
7.3.3 North America Compounding Pharmacies Market Size, By Country, 2024F (%)
7.3.4 U.S Compounding Pharmacies Market, By Value (2014-2018)
7.3.5 U.S Compounding Pharmacies Market, By Value (2019-2024)
7.3.6 Canada Compounding Pharmacies Market, By Value (2014-2018)
7.3.7 Canada Compounding Pharmacies Market, By Value (2019-2024)
7.4 Europe Compounding Pharmacies Market: Growth and Forecast
7.4.1 By Value (2014-2018)
7.4.2 By Value (2019-2024)
7.4.3 Europe Compounding Pharmacies Market- Company Share Analysis
7.4.4 By Product Type, By Value (2014-2018)
7.4.5 By Product Type, By Value (2019-2024)
7.4.6 By Therapeutic Area, By Value (2014-2018)
7.4.7 By Therapeutic Area, By Value (2019-2024)
7.4.8 By End User, By Value (2014-2018)
7.4.9 By End User, By Value (2019-2024)
7.5 Europe Compounding Pharmacies Market: Country Analysis (Germany, U.K)
7.5.1 Market Attractiveness Chart of Europe Compounding Pharmacies Market – By Country, By Value
7.5.2 Europe Compounding Pharmacies Market Size, By Country, 2018 (%)
7.5.3 Europe Compounding Pharmacies Market Size, By Country, 2024F (%)
7.5.4 Germany Compounding Pharmacies Market, By Value (2014-2018)
7.5.5 Germany Compounding Pharmacies Market, By Value (2019-2024)
7.5.6 U.K Compounding Pharmacies Market, By Value (2014-2018)
7.5.7 U.K Compounding Pharmacies Market, By Value (2019-2024)
7.6 APAC Compounding Pharmacies Market: Growth and Forecast
7.6.1 By Value (2014-2018)
7.6.2 By Value (2019-2024)
7.6.3 APAC Compounding Pharmacies Market- Competitive Landscape
7.6.4 By Product Type, By Value (2014-2018)
7.6.5 By Product Type, By Value (2019-2024)
7.6.6 By Therapeutic Area, By Value (2014-2018)
7.6.7 By Therapeutic Area, By Value (2019-2024)
7.6.8 By End User, By Value (2014-2018)
7.6.9 By End User, By Value (2019-2024)
7.6 APAC Compounding Pharmacies Market: Country Analysis (India, China, Japan)
7.6.1 Market Attractiveness Chart of APAC Compounding Pharmacies Market – By Country, By Value
7.6.2 APAC Compounding Pharmacies Market Size, By Country, 2018 (%)
7.6.3 APAC Compounding Pharmacies Market Size, By Country, 2024F (%)
7.6.4 India Compounding Pharmacies Market, By Value (2014-2018)
7.6.5 India Compounding Pharmacies Market, By Value (2019-2024)
7.6.6 China Compounding Pharmacies Market, By Value (2014-2018)
7.6.5 China Compounding Pharmacies Market, By Value (2019-2024)
7.6.6 Japan Compounding Pharmacies Market, By Value (2014-2018)
7.6.7 Japan Compounding Pharmacies Market, By Value (2019-2024)
7.7 ROW Compounding Pharmacies Market: Growth and Forecast
7.7.1 By Value (2014-2018)
7.7.2 By Value (2019-2024)
7.7.3 ROW Compounding Pharmacies Market- Company Share Analysis
7.7.4 By Product Type, By Value (2014-2018)
7.7.5 By Product Type, By Value (2019-2024)
7.7.6 By Therapeutic Area, By Value (2014-2018)
7.7.7 By Therapeutic Area, By Value (2019-2024)
7.7.8 By End User, By Value (2014-2018)
7.7.9 By End User, By Value (2019-2024)
7.8 ROW Compounding Pharmacies Market: Country Analysis (Brazil and Mexico)
7.8.1 Market Attractiveness Chart of APAC Compounding Pharmacies Market – By Country, By Value
7.8.2 ROW Compounding Pharmacies Market Size, By Country, 2018 (%)
7.8.3 ROW Compounding Pharmacies Market Size, By Country, 2024F (%)
7.8.4 Brazil Compounding Pharmacies Market, By Value (2014-2018)
7.8.5 Brazil Compounding Pharmacies Market, By Value (2019-2024)
7.8.6 Mexico Compounding Pharmacies Market, By Value (2014-2018)
7.8.7 Mexico Compounding Pharmacies Market, By Value (2019-2024)

8. Global Compounding Pharmacies Market Dynamics
8.1 Global Compounding Pharmacies Market Drivers
8.2 Global Compounding Pharmacies Market Restraints

9. Global Compounding Pharmacies Market Trends

10. Global Compounding Pharmacies Market
10.1 Competitive Landscape
10.2 Company Share Analysis
10.3 Merger and Acquisitions of Key Industry Players

11. Porter Five Force Analysis

12. SWOT Analysis

13. Policy and Regulatory Landscape

14. Company Profiles
14.1 Fagron
14.2 PharMEDium
14.3 Doughtery’s Pharmacy
14.4 ITC Compounding Pharmacy
14.5 Fresenius Kabi
14.6 Clinigen Group
14.7 Absolute Pharmacy
14.8 McGuff Compounding Pharmacies Services, Inc.
14.9 Pentec Health
14.10 Harrow Health, Inc.

List of Table

Table A: Estimated number of people living with cancer, 2020F and 2030F
Table B: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)
Table C: Prevailing risk factors for cardiovascular diseases across Brazil, In 2018 
Table D: Healthcare spending pattern in Brazil (In USD)
Table E: Recent Company Acquisitions and Mergers in Compounding Pharmacies Market
Table F: Recent Company Acquisitions and Mergers in Compounding Pharmacies Market
Table G: Compounding Pharmacy Regulatory Requirements

List of Chart

Figure 1: Compounding Pharmacies, Flowchart
Figure 2: Typical Pharmacy Compounding Operations
Figure 3: Global Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 4: Global Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 5: Share of People Aged 65+, 2015 and 2050F (In %)
Figure 6: Distributions of persons aged 60 years or above by region in millions, 2015 and 2030F
Figure 7: Projected global population (In Billions)
Figure 8: Projected global population aged 60 years & above (In Billions)
Figure 9: Prevalence of Cardiovascular Diseases Worldwide (In million)
Figure 10: Number of people with diabetes, Worldwide, (In million), 2017 & 2045E 
Figure 11: Key Facts & Figures About Diabetes, 2017
Figure 12: Projected increase in cases of diabetes in 2045, By region (In Percentage)
Figure 13: Top 10 countries for number of adults with diabetes (20-79 years), 2017, (In Million) 
Figure 14: Global Burden of Cancer
Figure 15: Global Prevalence of Different Type of Cancer, 2017 (In Thousands)
Figure 16: Global Prevalence of Prostate Cancer (2013-2017, Thousands)
Figure 17: Global Expected Healthcare Industry Outlook
Figure 18: Regional Expected Healthcare Industry Growth Rate By Year 2020
Figure 19: Key Factors Driving Global Healthcare Industry
Figure 20: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Figure 21: GDP Per Capita PPP, By Region, 2018 (in Thousand USD)
Figure 22: Global Compounding Pharmacies Market Size, By Product Type, By Value - 2018 (%)
Figure 23: Global Compounding Pharmacies Market Size, By Product Type, By Value - 2024F (%)
Figure 24: Global Compounding Pharmacies Market, By Oral Preparations, By Value, 2014-2018 (USD Million)
Figure 25: Global Compounding Pharmacies Market, By Oral Preparations, By Value, Forecast, 2019-2024 (USD Million)
Figure 26: Global Compounding Pharmacies Market, By Oral Preparations, By Value, 2014-2018 (USD Million)
Figure 27: Global Compounding Pharmacies Market, By Oral Preparations, By Value, Forecast, 2019-2024 (USD Million)
Figure 28: Global Compounding Pharmacies Market, By Ophthalmic Preparations, By Value, 2014-2018 (USD Million)
Figure 29: Global Compounding Pharmacies Market, By Ophthalmic Preparations, By Value, Forecast, 2019-2024 (USD Million)
Figure 30: Global Compounding Pharmacies Market, By Injectable Preparations, By Value, 2014-2018 (USD Million)
Figure 31: Global Compounding Pharmacies Market, By Injectable Preparations, By Value, Forecast, 2019-2024 (USD Million)
Figure 32: Global Compounding Pharmacies Market, By Other Preparations, By Value, 2014-2018, (USD Million)
Figure 33: Global Compounding Pharmacies Market, By Other Preparations, By Value, Forecast, 2019-2024 (USD Million)
Figure 34: Market Opportunity Chart of Global Compounding Pharmacies Market - By Product Type (Year-2024)
Figure 35: Global Compounding Pharmacies Market Size, By Therapeutic Area, By Value - 2018 (%)
Figure 36: Global Compounding Pharmacies Market Size, By Therapeutic Area, By Value - 2024F (%)
Figure 37: Global Compounding Pharmacies Market, By Hormone Replacement Application, By Value,2014-2018 (USD Million)
Figure 38: Global Compounding Pharmacies Market, By Hormone Replacement Application, By Value, Forecast, 2019-2024 (USD Million)
Figure 39: Global Compounding Pharmacies Market, By Pain Management Application, By Value, 2014-2018 (USD Million)
Figure 40: Global Compounding Pharmacies Market, By Pain Management Application, By Value, Forecast, 2019-2024 (USD Million)
Figure 41: Global Compounding Pharmacies Market, By Dermatology Application, By Value, 2014-2018 (USD Million)
Figure 42: Global Compounding Pharmacies Market, By Dermatology Application, By Value, Forecast, 2019-2024 (USD Million)
Figure 43: Global Compounding Pharmacies Market, By Other Therapeutic Areas, By Value, 2014-2018 (USD Million)
Figure 44: Global Compounding Pharmacies Market, By Other Therapeutic Areas, By Value, Forecast, 2019-2024 (USD Million)
Figure 45: Market Opportunity Chart of Global Compounding Pharmacies Market - By Therapeutic Area (Year-2024)
Figure 46: Global Compounding Pharmacies Market Size, By End User, By Value - 2018 (%)
Figure 47: Global Compounding Pharmacies Market Size, By End User, By Value - 2024F (%)
Figure 48: Global Compounding Pharmacies Market, By Adult End User, By Value, 2014-2018 (USD Million)
Figure 49: Global Compounding Pharmacies Market, By Adult End User, By Value, Forecast, 2019-2024 (USD Million)
Figure 50: Global Compounding Pharmacies Market, By Pediatric End User, By Value, 2014-2018 (USD Million)
Figure 51: Global Compounding Pharmacies Market, By Pediatric End User, By Value, Forecast, 2019-2024 (USD Million)
Figure 52: Global Compounding Pharmacies Market, By Geriatric End User, By Value, 2014-2018 (USD Million)
Figure 53: Global Compounding Pharmacies Market, By Geriatric End User, By Value, Forecast, 2019-2024 (USD Million)
Figure 54: Global Compounding Pharmacies Market, By Veterinary End User, By Value, 2014-2018 (USD Million)
Figure 55: Global Compounding Pharmacies Market, By Veterinary End User, By Value, Forecast, 2019-2024 (USD Million)
Figure 56: Market Opportunity Chart of Global Compounding Pharmacies Market - By End User (Year-2024)
Figure 57: Global Healthcare Landscape, By Select Region
Figure 58: Global Compounding Pharmacies Market Size, By Region, 2018 (%)
Figure 59: Global Compounding Pharmacies Market Size, By Region, 2024F (%)
Figure 60: North America Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 61: North America Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 62: North America GDP, 2012-2018 (USD Trillion)
Figure 63: North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 64: North America, Adjusted net national income per capita, 2012-2017 (current USD)
Figure 65: North America Population above 65 year, 2015, 2030F, & 2050F (In Millions) 
Figure 66: Prevalence of Diabetes in North America, 2017 & 2045E (In Million)
Figure 67: North America, Population Projections (In Millions)
Figure 68: Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds)
Figure 69: North America, Cancer Incidence (In Millions)
Figure 70: North America, Cancer Incidence, By Route of Administration, 2019E (In %)
Figure 71: Prevalence of Obesity in United States Among Populace Aged Above 20, 2013-2017 (% of total)
Figure 72: Prevalence of cardiovascular disease in North America, In million
Figure 73: North America, Company Share Analysis, 2018 (In %)
Figure 74: North America Compounding Pharmacies Market: By Product Type, By Value, 2014-2018 (USD Million)
Figure 75: North America Compounding Pharmacies Market: By Product Type, By Value, 2019E-2024F (USD Million)
Figure 76: North America Compounding Pharmacies Market: By Therapeutic Area, By Value, 2014-2018 (USD Million)
Figure 77: North America Compounding Pharmacies Market: By Therapeutic Area, By Value, 2019E-2024F (USD Million)
Figure 78: North America Compounding Pharmacies Market: By End User, By Value, 2014-2018 (USD Million)
Figure 79: North America Compounding Pharmacies Market: By End User, By Value, 2019E-2024F (USD Million)
Figure 80: Market Opportunity Chart of North America Compounding Pharmacies Market - By Country, By Value (Year-2024)
Figure 81: North America Compounding Pharmacies Market, Country Share, 2018 (%)
Figure 82: North America Compounding Pharmacies Market, Country Share, 2024F (%)
Figure 83: U.S. Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 84: U.S. Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 85: U.S., Population ages 65 and above, 2014-2018 (% of total)
Figure 86: Total national health expenditures, 2018
Figure 87: United States, GDP, 2012-2022F (In USD Billion)
Figure 88: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD)
Figure 89: United States, Number of Individuals Aged 65+, (In Million)
Figure 90: U.S, Population Projections (In Millions)
Figure 91: Canada Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 92: Canada Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 93: Canada, GDP, 2012-2022F (In USD Billion)
Figure 94: Canada, Health Care Spending, Key Facts, 2018
Figure 95: Canada, Population ages 65 and above, 2014-2018 (% of total)
Figure 96: Canada, Population Ageing Key Facts
Figure 97: Prevalence of Diabetics in Canada, (% of Total Population) 2015 & 2045F
Figure 98: Estimated Prevalence of Pre-Diabetics in Canada, (% of Total Population) 2015 & 2045F
Figure 99: Canada, Population Projections (In Millions)
Figure 100: Prevalence of Chronic Diseases Among Canadian Adults
Figure 101: Europe Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 102: Europe Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 103: European Country Population Aged 65 and Above, 2014-2018 (% of Total)
Figure 104: Euro Area, Population ages 65 years and above (% of total population), 2014-2018
Figure 105: Breakdown of Total Health Expenditure in Europe, 2018 (%)
Figure 106: Prevalence of Diabetes (Age 18+), 2017 & 2045E (In Million)
Figure 107: North America, Company Share Analysis, 2018 (In %)
Figure 108: Europe Compounding Pharmacies Market: By Product Type, By Value, 2014-2018 (USD Million)
Figure 109: Europe Compounding Pharmacies Market: By Product Type, By Value, 2019E-2024F (USD Million)
Figure 110: Europe Compounding Pharmacies Market: By Therapeutic Area, By Value, 2014-2018 (USD Million)
Figure 111: Europe Compounding Pharmacies Market: By Therapeutic Area, By Value, 2019E-2024F (USD Million)
Figure 112: Europe Compounding Pharmacies Market: By End User, By Value, 2014-2018 (USD Million)
Figure 113: Europe Compounding Pharmacies Market: By End User, By Value, 2019E-2024F (USD Million)
Figure 114: Market Opportunity Chart of Europe Compounding Pharmacies Market - By Country, By Value (Year-2024)
Figure 115: Europe Compounding Pharmacies Market, Country Share, 2018 (%)
Figure 116: Europe Compounding Pharmacies Market, Country Share, 2024F (%)
Figure 117: Germany Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 118: Germany Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 119: Germany, Current Expenditure on Health (All Functions) as a share of GDP, 2014-2018 
Figure 120: Germany, Population ages 65 and above, 2012-2017 (% total)
Figure 121: Prevalence of Different Type of Cancer in Germany in year 2016 & 2017 ( In Hundreds)
Figure 122: U.K Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 123: U.K Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 124: Cancer Statistics in the United Kingdom
Figure 125: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 126: Prevalence of cardiovascular diseases in United Kingdom, In million
Figure 127: U.K, Population Ages 65 and Above (% of total), 2012-2018
Figure 128: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 129: APAC Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 130: APAC Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 131: Population ages 65 and above, APAC Region, 2018 (% of total) 
Figure 132: Population ages 65 and above, APAC Region, By Select Country, 2050 (% of total) 
Figure 133: APAC - Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2017
Figure 134: APAC - Obesity Rate, By Select Country, 2017 (In Percentage)
Figure 135: East Asia and Pacific, Share of urban population, 2013-2018 (In %) 
Figure 136: Prevalence of cardiovascular diseases in APAC region, In million
Figure 137: APAC, Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 138: Estimated number of deaths from prostate cancer in 2012 and 2030
Figure 139: APAC Compounding Pharmacies Market: By Product Type, By Value, 2014-2018 (USD Million)
Figure 140: APAC Compounding Pharmacies Market: By Product Type, By Value, 2019E-2024F (USD Million)
Figure 141: APAC Compounding Pharmacies Market: By Therapeutic Area, By Value, 2014-2018 (USD Million)
Figure 142: APAC Compounding Pharmacies Market: By Therapeutic Area, By Value, 2019E-2024F (USD Million)
Figure 143: APAC Compounding Pharmacies Market: By End User, By Value, 2014-2018 (USD Million)
Figure 144: APAC Compounding Pharmacies Market: By End User, By Value, 2019E-2024F (USD Million)
Figure 145: Market Opportunity Chart of APAC Compounding Pharmacies Market - By Country, By Value (Year-2024)
Figure 146: APAC Compounding Pharmacies Market, Country Share, 2018 (%)
Figure 147: APAC Compounding Pharmacies Market, Country Share, 2024F (%)
Figure 148: India Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 149: India Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 150: India, Total Population, 2013-2023F (In Billion)
Figure 151: India, Share of Urban Population, 2012-2018 (In %)
Figure 152: India, GDP Growth Per Year, 2015-2019 (In %)
Figure 153: India, Total deaths due to cancer, 2018
Figure 154: Top 5 forms of cancer in men and women in India
Figure 155: Population ages 65 and above, 2013-2018 (% of total)
Figure 156: India, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 157: China Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 158: China Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 159: China, GDP Growth Per Year, 2015-2019 (In %)
Figure 160: China, Total Population, 2013-2021F (In Billion)
Figure 161: China, Share of Urban Population, 2012-2018 (In %)
Figure 162: China, Adjusted net national income per capita (Current USD) 
Figure 163: China, Population ages 65 and above, 2013-2018 (% of total) 
Figure 164: Number of new cancer cases, Males (all ages), 2018 (In %)
Figure 165: Number of new cancer cases, Females(all ages), 2018 (In %)
Figure 166: Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds)
Figure 167: China, Cancer Mortality Rate, By Cancer Site, 2018
Figure 168: Japan Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 169: Japan Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 170: Japan, Population ages 65 and above, 2012-2018 (% of total)
Figure 171: Japan, GDP Growth Per Year, 2015-2019F (In %)
Figure 172: Japan Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 173: Total Number of People With Cardiovascular Disorders in Japan, By Type, 2017 (In thousands)
Figure 174: Prevalence of Different Type of Cancer in Japan in year 2016 & 2017 ( In Hundreds)
Figure 175: ROW Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 176: ROW Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 177: North Africa and Middle East Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 178: Middle East and North Africa, GDP, 2012-2018 (In USD Trillion)
Figure 179: ROW, Population ages 60 or above, By Select Country, 2050F (% of total)
Figure 180: Population ages 65 and above, Middle East and North Africa Region, 2012-2018 (% of total) 
Figure 181: Population ages 65 and above, Latin America and Caribbean Region, 2012-2018 (% of total) 
Figure 182: Cancer Prevalence in MENA (% of total), 2018
Figure 183: Top 10 fastest growing economies, 2018, (In%)
Figure 184: Prevalence of Different Type of Cancer in Middle East and North Africa in year 2016 & 2017 ( In Hundreds)
Figure 185: Total Number of People With Cardiovascular Disorders in North Africa and Middle East, By Type, 2017 (In thousands)
Figure 186: ROW Compounding Pharmacies Market: By Product Type, By Value, 2014-2018 (USD Million)
Figure 187: ROW Compounding Pharmacies Market: By Product Type, By Value, 2019E-2024F (USD Million)
Figure 188: ROW Compounding Pharmacies Market: By Therapeutic Area, By Value, 2014-2018 (USD Million)
Figure 189: ROW Compounding Pharmacies Market: By Therapeutic Area, By Value, 2019E-2024F (USD Million)
Figure 190: ROW Compounding Pharmacies Market: By End User, By Value, 2014-2018 (USD Million)
Figure 191: ROW Compounding Pharmacies Market: By End User, By Value, 2019E-2024F (USD Million)
Figure 192: Market Opportunity Chart of ROW Compounding Pharmacies Market - By Country, By Value (Year-2024)
Figure 193: ROW Compounding Pharmacies Market, Country Share, 2018 (%)
Figure 194: ROW Compounding Pharmacies Market, Country Share, 2024F (%)
Figure 195: Brazil Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 196: Brazil Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 197: Brazil Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 198: Total Number of People With Cardiovascular Disorders in Brazil, By Type,2017 (In thousands)
Figure 199: Prevalence of Different Type of Cancer in Brazil in year 2016 & 2017 ( In Hundreds)
Figure 200: Prevalence of cardiovascular disease in Brazil, In Billion 
Figure 201: Brazil health expenditure as a share of GDP, 2018 
Figure 202: Brazil, Population ages 65 and above, 2012-2018 (In Percentage)
Figure 203: Mexico Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 204: Mexico Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 205: Key Drivers of Compounding Pharmacies Market in Mexico
Figure 206: Mexico, Compounding Pharmacies Market, Key Traits
Figure 207: Mexico, Population ages 65 and above, 2012-2018 (In Percentage) 
Figure 208: FDA Compounding Inspection Activity, (As of June 2017)
Figure 209: Fagron, Business Verticals
Figure 210: Fagron, Revenue, 2014-2018 (In USD Million)
Figure 211: Fagron, Revenue, By Business Segment, 2018 (In %)
Figure 212: Fagron, Net Sales, By Geographic Region, 2018 (In %)
Figure 213: Dougherty’s Pharmacy, Revenue, 2014-2018 (In USD Million)
Figure 214: Fresenius Kabi, Revenue, 2015-2018 (USD Billion)
Figure 215: Fresenius Kabi, By Product Group, 2018 (%)
Figure 216: Fresenius Kabi, By Region, 2018 (%)
Figure 217: Clinigen Group, Revenue, 2014-2018 (In USD Million)
Figure 218: Clinigen Group, Revenue, By Business Segment, 2018 (In %)
Figure 219: Clinigen Group, Adjusted Gross Profit, By Geographic Region, 2018 (In %)
Figure 220: Clinigen Group, Adjusted Gross Profit, By Client/Customer, 2018 (In %)
Figure 221: Harrow Health, Inc., Revenue, 2014-2018 (In USD Million)

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 2400
$ 3000

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top